Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Finch Therapeutics Group, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 17 | 0 |
| Shares | 243.6K | 45.6K | 209.2K | +11.2K (+5.7%) |
| Value | $1.37M | $236.5K | $754.7K | −$378.0K (−33.4%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 11,746 | $42.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 141 | $509 | 0.00% |
| Bank of America Corp | 12 | $43 | 0.00% |
Sold out (3)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| MSD Partners, L.P. | 5,113 | $26.5K |
| Ancora Advisors, LLC | 533 | $2.76K |
| Steward Partners Investment Advisory, LLC | 75 | $389 |
Not filed for Q4 2023 yet (1)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Avenir Management Company, LLC | 45,650 | $236.5K |